
Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
| Revenue (TTM) | $3.41B |
| Gross Profit (TTM) | $1.40B |
| EBITDA | $535.06M |
| Operating Margin | 12.70% |
| Return on Equity | -40.50% |
| Return on Assets | 3.48% |
| Revenue/Share (TTM) | $37.62 |
| Book Value | $22.25 |
| Price-to-Book | 1.60 |
| Price-to-Sales (TTM) | 1.01 |
| EV/Revenue | 1.633 |
| EV/EBITDA | 9.47 |
| Quarterly Earnings Growth (YoY) | -5.10% |
| Quarterly Revenue Growth (YoY) | 5.10% |
| Shares Outstanding | $92.97M |
| Float | $91.40M |
| % Insiders | 1.54% |
| % Institutions | 148.35% |
Volatility is currently expanding

Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.

Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Acadia Healthcare NASDAQ: ACHC raised its full-year 2026 financial guidance for the third consecutive quarter after reporting third-quarter revenue growth and stronger-than-expected adjusted earnings, executives said on the company's earnings call.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. On Monday, November 9, 2026, the Company will participate in the 2026 UBS Global Healthcare Conference. The Company's presentation will begin at 11:00 a.m. Eastern Time/10:00 a.m. Central Time. On Wednesday, November 18, 2026, the Company will participate in the 2026 Stephens Annual Investment Conference. The Company's presen.

GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Thursday, November 5, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be a.

Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here is how Acadia Healthcare (ACHC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACHC and any ticker you trade — then tracks every position and per-strategy win rate.